Navigation Links
Researchers Identify Contaminant in Tainted Heparin
Date:4/23/2008

More testing needed to prove that oversulfated chondroitin sulphate caused deaths, reactions

WEDNESDAY, April 23 (HealthDay News) -- U.S. researchers say they've confirmed that lots of the blood thinner heparin pulled from the market are contaminated with a man-made chemical called oversulfated chondroitin sulfate.

The findings were published online Wednesday in Nature Biotechnology.

And, according to a paper published online simultaneously in the New England Journal of Medicine, the same researchers state that regulators now have at their disposal a test to detect contaminated heparin.

Regulators have said they have been hampered in their efforts to safeguard the public from contaminated heparin because of an uncertainty over exactly what the contaminant is and the lack of a test to spot such a contaminant.

"Sophisticated analytical techniques enabled complete characterization of the contaminant present in heparin. Further, this study also provides the scientific groundwork for critical improvements in screening practices that can now be applied to monitor heparin, thus ensuring patient safety," Ram Sasisekharan, senior author of the papers and the Underwood Prescott Professor of Biological Engineering and Health Sciences and Technology at Massachusetts Institute of Technology, said in a prepared statement.

On Monday, U.S. health officials said they believed that oversulfated chondroitin sulfate (OSCS) might be responsible for the dozens of deaths and hundreds of adverse reactions in the United States that have been linked with contaminated heparin between roughly last November and February.

That belief was bolstered by the fact that the U.S. Food and Drug Administration said it had identified a likely "biological mechanism" by which the oversulfated chondroitin sulfate leads to the adverse reactions seen so far, Dr. Janet Woodcock, director of the FDA's Center for Drug
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. UMass Medical School researchers awarded pediatric HIV vaccine development grant
2. Researchers identify new cell targets for preventing growth of breast and other tumors
3. Melanoma lurks in larger skin lesions, NYU researchers find
4. Reduced Funds for Cancer is Cost of Iraq, Say Ex-White House Aide, Cancer Researchers
5. MU researchers reveal communication tactics used by sexual predators to entrap children
6. Penn researchers find potential in yeast for selecting Lou Gehrigs disease drugs
7. MU researchers find clue to cataract formation
8. Researchers evaluating food allergy treatment
9. U of M researchers identify process that may help treat Parkinsons, spinal cord injuries
10. OHSU Cancer Institute researchers discover key gene involvement in cancer development
11. Combining liver cancer treatments doubles survival rates, UVA researchers find
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researchers Identify Contaminant in Tainted Heparin
(Date:7/31/2015)... ... , ... The Honor Society of Nursing, Sigma Theta Tau International (STTI) convened ... 20-21 July 2015 in San Juan, Puerto Rico. Key nurse leaders from Central and ... Advisor, Nursing and Allied Health Personnel Development, Unit of Human Resources for Health, Department ...
(Date:7/31/2015)... Atlanta, GA (PRWEB) , ... July 31, 2015 ... ... the five new industry players to know in predictive health analytics , ... machine learning technologies. The firm creates predictive software that targets patient and population ...
(Date:7/31/2015)... ... July 31, 2015 , ... There’s no better way to ... it comes time to cook the next meal, making July the most appropriate to ... best grilling tips and recipes. , Make the next cookout different than the ones ...
(Date:7/31/2015)... , ... July 31, 2015 , ... M3 USA MDLinx.com, ... to launch three new Board Exam Courses. , The additions of Gastroenterology, Pulmonology ... Exam Prep from MDLinx makes preparing for the exam easy and painless. MDLinx ...
(Date:7/31/2015)... ... 31, 2015 , ... Well-known for its unique pastries and delicious confections, Pastry ... custom designs, making life just a little bit sweeter for newlyweds. A family-owned business, ... who orders one. , The bakery provides a full line of custom wedding cakes. ...
Breaking Medicine News(10 mins):Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 2Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 3Health News:Key Latin American Nurse Leaders Identify Regional Issues During Global Advisory Panel on the Future of Nursing Meeting 4Health News:Jvion Showcased as Leader in the Predictive Analytic Market 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 2Health News:King Kullen Honors National Hot Dog and Blueberry Month 3Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 2Health News:MDLinx Offers Three New Board Exam Prep Courses - Gastroenterology, Pulmonology and Allergy/Immunology 3Health News:Pastry Palace of Las Vegas Announces It Is Now Offering Custom Wedding Cakes in Las Vegas 2
... MILLS, Md., July 31 Medifast, Inc.,(NYSE: ... published in ,The Journal,of Eating and Weight Disorders, ... double the weight loss when they combine,their drug ... Replacement,Supplements., The 52-week study, conducted by researchers ...
... Center Unveils New Report Based on Internal ... to a new,Center for Public Integrity investigation, Perils ... were responsible for more than 26 percent of ... the United States in 2007,up from just 15 ...
... City Area, MERRIMACK, N.H., July 31 ... Medical Inc. announced today that Gary D.,Hall, MD, ... to offer the,SmoothShapes(R) system for longer-lasting cellulite treatment ... Northland Kansas City. Rajeunir,is hosting a SmoothShapes open ...
... Two new studies examine the use of the nucleoside ... C. The reports appear in the August issue of ... & Sons on behalf of the American Association for ... available online at Wiley Interscience ( www.interscience.wiley.com ). ...
... to recognize and treat schizophrenic disorders at an earlier ... prognosis, which has often been unfavorable. In the latest ... Arztebl Int 2008; 105[30]: 532-9), Joachim Klosterktter of ... describes the current state of research into the prevention ...
... PPG to Offer Groundbreaking The Prevention Plan ... U.S. Preventive Medicine,( http://www.USPreventiveMedicine.com ), the leader ... announced today they have formed a,strategic alliance ... the ability,to offer U.S. Preventive Medicine,s groundbreaking ...
Cached Medicine News:Health News:Medifast Program Combined with Appetite Suppressants Proven to Yield Double the Weight Loss Compared to Suppressants Alone 2Health News:'Safe' Pesticides Now First in Poisonings 2Health News:'Safe' Pesticides Now First in Poisonings 3Health News:New Anti-Cellulite Treatment Prepares Women for Warmer Weather and Beyond 2Health News:New Anti-Cellulite Treatment Prepares Women for Warmer Weather and Beyond 3Health News:New treatment therapy helps inhibit hepatitis C 2Health News:U.S. Preventive Medicine(R) Forms Strategic Alliance with Physicians Planning Group 2Health News:U.S. Preventive Medicine(R) Forms Strategic Alliance with Physicians Planning Group 3
(Date:7/31/2015)... -- Quietly, sedately, Morocco,s pharmaceutical sector is ... industry is strong, with a well-developed base of local ... One place where the quality of Moroccan ... has quietly become the second largest African exporter of ... Indeed, Moroccan pharma companies have been making inroads as ...
(Date:7/31/2015)... N.J. and SAN DIEGO ... that its parent company Eisai Co., Ltd. (Headquarters: ... Naito , "Eisai") and Halozyme Therapeutics, Inc. (Headquarters: ... Dr. Helen Torley , "NASDAQ: HALO") have signed ... (brand name: Halaven ® , "eribulin") in combination with ...
(Date:7/31/2015)... India , July 31, 2015 ... CRM solutions for video, data and cloud computing ... with a leading pharma giant for Internet of ... different IoT applications offered on subscription model. ... Pharma giant is striving for business innovations ...
Breaking Medicine Technology:PharmaBoardroom Releases New Morocco Pharmaceuticals Report 2PharmaBoardroom Releases New Morocco Pharmaceuticals Report 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 2Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 3Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 4Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 5Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer 6Magnaquest Signs a POC With a Leading Pharma Giant in Europe to Manage Subscription Management and Billing for Internet of Things (IoT) 2
... MADISON, Conn., Aug 31 The results of the initial ... invasive treatment for varicose veins, will be delivered on Wednesday, September ... Phlebologie in Monaco. The device combines mechanical and chemical modalities to ... Speaking is Steve Elias MD FACS FACPh, Associate Professor of ...
... , , PARIS, ... will present initial results of the CURRENT-OASIS 7 clinical trial at ... SAN, and NYSE: SNY ) and Bristol-Myers Squibb (NYSE: ... bisulfate), were sponsors of the study. , , ...
Cached Medicine Technology:ClariVein(TM) Catheter for Varicose Veins: Clinical Trial Results to be Presented 2New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty 2New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty 3New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty 4New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of PLAVIX(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: